CL2019001417A1 - Composición cosmética antisenescencia celular, uso de derivados de casearia sylvestris y/o hymenaea courbaril, método de prevención de la senescencia celular y método para la modulación de la expresión de b-galactosidasa, p16, p21 y/o il-8. - Google Patents

Composición cosmética antisenescencia celular, uso de derivados de casearia sylvestris y/o hymenaea courbaril, método de prevención de la senescencia celular y método para la modulación de la expresión de b-galactosidasa, p16, p21 y/o il-8.

Info

Publication number
CL2019001417A1
CL2019001417A1 CL2019001417A CL2019001417A CL2019001417A1 CL 2019001417 A1 CL2019001417 A1 CL 2019001417A1 CL 2019001417 A CL2019001417 A CL 2019001417A CL 2019001417 A CL2019001417 A CL 2019001417A CL 2019001417 A1 CL2019001417 A1 CL 2019001417A1
Authority
CL
Chile
Prior art keywords
antisenescence
derivatives
cosmetic composition
galactosidase
modulation
Prior art date
Application number
CL2019001417A
Other languages
English (en)
Inventor
Daniela Zimbardi
De Oliveira Ana Paula Pedroso
Kelen Fabiola Arroteia
Michele Cristiane Bufalo
Original Assignee
Natura Cosmeticos Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natura Cosmeticos Sa filed Critical Natura Cosmeticos Sa
Publication of CL2019001417A1 publication Critical patent/CL2019001417A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/76—Salicaceae (Willow family), e.g. poplar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions
    • A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Cosmetics (AREA)

Abstract

LA PRESENTE INVENCIÓN TRATA DE UNA COMPOSICIÓN COSMÉTICA ANTISENESCENCIA CELULAR QUE COMPRENDE UNO O MÁS DERIVADOS DE CASEARIA SYLVESTRIS, HYMENAEA COURBARIL O SUS MEZCLAS Y EXCIPIENTES COSMÉTICAMENTE ACEPTABLES, ASÍ COMO USOS Y MÉTODOS DE PREVENCIÓN RELACIONADOS.
CL2019001417A 2016-11-28 2019-05-24 Composición cosmética antisenescencia celular, uso de derivados de casearia sylvestris y/o hymenaea courbaril, método de prevención de la senescencia celular y método para la modulación de la expresión de b-galactosidasa, p16, p21 y/o il-8. CL2019001417A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15/362,256 US20180147134A1 (en) 2016-11-28 2016-11-28 Anti-cell senescence cosmetic composition, use of casearia sylvestris and/or himenaea courbaril, method of preventing cell senescence and a method for modulating the expression of b-galactosidase, p16, p21 and/or il-8

Publications (1)

Publication Number Publication Date
CL2019001417A1 true CL2019001417A1 (es) 2019-08-09

Family

ID=62193003

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019001417A CL2019001417A1 (es) 2016-11-28 2019-05-24 Composición cosmética antisenescencia celular, uso de derivados de casearia sylvestris y/o hymenaea courbaril, método de prevención de la senescencia celular y método para la modulación de la expresión de b-galactosidasa, p16, p21 y/o il-8.

Country Status (7)

Country Link
US (1) US20180147134A1 (es)
EP (1) EP3545946A1 (es)
AR (1) AR110260A1 (es)
BR (1) BR112019009838A2 (es)
CL (1) CL2019001417A1 (es)
MX (1) MX2019005977A (es)
WO (1) WO2018094495A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023015364A1 (pt) * 2021-08-12 2023-02-16 Natura Cosméticos S.A. Composição cosmética, uso de casearia sylvestris, schinus terebinthifolius, hymenaea courbaril e lactobacillus e método de prevenção e/ou tratamento de sinais resultantes do envelhecimento da pele

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3650245B2 (ja) * 1997-02-27 2005-05-18 御木本製薬株式会社 美白化粧品
JP2003055190A (ja) * 2001-08-07 2003-02-26 Koei Kogyo Kk コラゲナーゼ阻害剤及び抗老化用化粧料
JP2006241102A (ja) * 2005-03-04 2006-09-14 Kanebo Cosmetics Inc Ｓｃｆ遊離抑制剤及び皮膚外用組成物
FR2932803B1 (fr) * 2008-06-19 2012-04-20 Natura Cosmeticos Sa Procede d'obtention de polysaccharides a partir de semences de jatoba, composition cosmetique comprenant lesdits polysaccharides
FR3010313A1 (fr) * 2013-09-09 2015-03-13 Natura Cosmeticos Sa Composition comprenant un extrait de guacatonga et un extrait d'aroeira, son utilisation et methode pour empecher et/ou traiter les signes causes par le vieillissement de la peau
EP3466407A4 (en) * 2016-05-24 2020-07-22 Natura Cosméticos S.A. COMPOSITION FOR MODULATING THE GENES RESPONSIBLE FOR GENERAL SKIN FUNCTIONS, METHOD FOR MODULATING THE EXPRESSION OF GENES RESPONSIBLE FOR GENERAL SKIN FUNCTIONS AND USE OF A VEGETABLE EXTRACT
BR102016019117B1 (pt) * 2016-08-17 2021-08-17 Natura Cosméticos S.A. Composição cosmética antissinais, uso da composição, método para tratamento antissinais e método para recuperação da firmeza e elasticidade da pele do rosto

Also Published As

Publication number Publication date
EP3545946A4 (en) 2019-10-02
BR112019009838A2 (pt) 2019-08-20
MX2019005977A (es) 2019-08-14
WO2018094495A1 (pt) 2018-05-31
AR110260A1 (es) 2019-03-13
EP3545946A1 (en) 2019-10-02
US20180147134A1 (en) 2018-05-31

Similar Documents

Publication Publication Date Title
CL2021000704A1 (es) Anticuerpos contra proteína alfa reguladora de señal y métodos de uso. (divisional de solicitud 668-2019)
UY37381A (es) Compuestos que inhiben proteasas 3c y 3cl y métodos de uso de los mismos
CL2016003398A1 (es) Compuestos de heteroarilo útiles como inhibidores de enzima activadora de sumo.
CL2017002422A1 (es) Derivados de maitansinoide, conjugados de los mismos, y métodos de uso.
CL2020000281A1 (es) Anticuerpos anti-cd39, composiciones que comprenden anticuerpos anti-cd39 y métodos de uso de anticuerpos anti-cd39
CL2020000060A1 (es) Compuestos antiproliferativos y métodos para utilizarlos.
CL2018002012A1 (es) Derivados de maitansinoide, conjugados de los mismos y métodos de uso.
NI201800055A (es) Anticuerpos que se unen específicamente a pd-1 y sus usos.
CR20160500A (es) Anticuerpos anti-ox40 y métodos de uso
ECSP17016797A (es) Indazoles sustituidos con benzilo como inhibidores de bub1
MX2017010667A (es) Anticuerpos anti-proteína que contiene domino de inmunologlubina relacionado con el receptor de poliovirus (pvrig) y metodos de unso.
BR112019012343A2 (pt) anticorpos il-11ra
CR20170240A (es) Anticuerpos anti-interleucina-33 y sus usos
EP3926038A3 (en) Functional expression of monooxygenases and methods of use
BR112017004802A2 (pt) anticorpos anti-cll-1 e imunoconjugados
CR20190271A (es) Anticuerpos antitau y métodos de uso
EP4335874A3 (en) Anti-hla-g antibodies and use thereof
CR20160362A (es) Anticuerpos anti-jagged1 y metodos de uso
AR101905A1 (es) Compuestos bicíclicos
AU2016263598A8 (en) Methods and kits for treating depression
BR112017013568A2 (pt) compostos bicíclicos fundidos para o tratamento de doenças
BR112017004444A2 (pt) novos anticorpos anti-mfi2 e métodos de uso
BR112017012210A2 (pt) solução conservante de célula, uso da mesma e método de produção de solução conservante de célula
MX2016009858A (es) Fusiones anti proteína convertasa subtilisina/kexina tipo 9 (anti-pcsk9)n péptido 1 similar a glucagón (glp-1) y métodos de uso.
BR112018071600A2 (pt) métodos, composições e usos relacionados aos mesmos